Depletion of cardiac cardiolipin synthase alters systolic and diastolic function
Summary: Cardiolipin (CL) is a major cardiac mitochondrial phospholipid maintaining regular mitochondrial morphology and function in cardiomyocytes. Cardiac CL production includes its biosynthesis and a CL remodeling process. Here we studied the impact of CL biosynthesis and the enzyme cardiolipin s...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/495faf1d987c41ec8b93ea96ff9681f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:495faf1d987c41ec8b93ea96ff9681f2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:495faf1d987c41ec8b93ea96ff9681f22021-11-20T05:09:50ZDepletion of cardiac cardiolipin synthase alters systolic and diastolic function2589-004210.1016/j.isci.2021.103314https://doaj.org/article/495faf1d987c41ec8b93ea96ff9681f22021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S2589004221012839https://doaj.org/toc/2589-0042Summary: Cardiolipin (CL) is a major cardiac mitochondrial phospholipid maintaining regular mitochondrial morphology and function in cardiomyocytes. Cardiac CL production includes its biosynthesis and a CL remodeling process. Here we studied the impact of CL biosynthesis and the enzyme cardiolipin synthase (CLS) on cardiac function. CLS and cardiac CL species were significantly downregulated in cardiomyocytes following catecholamine-induced cardiac damage in mice, accompanied by increased oxygen consumption rates, signs of oxidative stress, and mitochondrial uncoupling. RNAi-mediated cardiomyocyte-specific knockdown of CLS in Drosophila melanogaster resulted in marked cardiac dilatation, severe impairment of systolic performance, and slower diastolic filling velocity assessed by fluorescence-based heart imaging. Finally, we showed that CL72:8 is significantly decreased in cardiac samples from patients with heart failure with reduced ejection fraction (HFrEF). In summary, we identified CLS as a regulator of cardiac function. Considering the cardiac depletion of CL species in HFrEF, pharmacological targeting of CLS may be a promising therapeutic approach.Elia SmeirSarah LebererAnnelie BlumrichGeorg VoglerAnastasia VasiliadesSandra DresenCarsten JaegerYoann GloaguenChristian KloseDieter BeuleP. Christian SchulzeRolf BodmerAnna Foryst-LudwigUlrich KintscherElsevierarticleAnimal physiologyMolecular physiologyMolecular biologyLipidomicsScienceQENiScience, Vol 24, Iss 11, Pp 103314- (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Animal physiology Molecular physiology Molecular biology Lipidomics Science Q |
spellingShingle |
Animal physiology Molecular physiology Molecular biology Lipidomics Science Q Elia Smeir Sarah Leberer Annelie Blumrich Georg Vogler Anastasia Vasiliades Sandra Dresen Carsten Jaeger Yoann Gloaguen Christian Klose Dieter Beule P. Christian Schulze Rolf Bodmer Anna Foryst-Ludwig Ulrich Kintscher Depletion of cardiac cardiolipin synthase alters systolic and diastolic function |
description |
Summary: Cardiolipin (CL) is a major cardiac mitochondrial phospholipid maintaining regular mitochondrial morphology and function in cardiomyocytes. Cardiac CL production includes its biosynthesis and a CL remodeling process. Here we studied the impact of CL biosynthesis and the enzyme cardiolipin synthase (CLS) on cardiac function. CLS and cardiac CL species were significantly downregulated in cardiomyocytes following catecholamine-induced cardiac damage in mice, accompanied by increased oxygen consumption rates, signs of oxidative stress, and mitochondrial uncoupling. RNAi-mediated cardiomyocyte-specific knockdown of CLS in Drosophila melanogaster resulted in marked cardiac dilatation, severe impairment of systolic performance, and slower diastolic filling velocity assessed by fluorescence-based heart imaging. Finally, we showed that CL72:8 is significantly decreased in cardiac samples from patients with heart failure with reduced ejection fraction (HFrEF). In summary, we identified CLS as a regulator of cardiac function. Considering the cardiac depletion of CL species in HFrEF, pharmacological targeting of CLS may be a promising therapeutic approach. |
format |
article |
author |
Elia Smeir Sarah Leberer Annelie Blumrich Georg Vogler Anastasia Vasiliades Sandra Dresen Carsten Jaeger Yoann Gloaguen Christian Klose Dieter Beule P. Christian Schulze Rolf Bodmer Anna Foryst-Ludwig Ulrich Kintscher |
author_facet |
Elia Smeir Sarah Leberer Annelie Blumrich Georg Vogler Anastasia Vasiliades Sandra Dresen Carsten Jaeger Yoann Gloaguen Christian Klose Dieter Beule P. Christian Schulze Rolf Bodmer Anna Foryst-Ludwig Ulrich Kintscher |
author_sort |
Elia Smeir |
title |
Depletion of cardiac cardiolipin synthase alters systolic and diastolic function |
title_short |
Depletion of cardiac cardiolipin synthase alters systolic and diastolic function |
title_full |
Depletion of cardiac cardiolipin synthase alters systolic and diastolic function |
title_fullStr |
Depletion of cardiac cardiolipin synthase alters systolic and diastolic function |
title_full_unstemmed |
Depletion of cardiac cardiolipin synthase alters systolic and diastolic function |
title_sort |
depletion of cardiac cardiolipin synthase alters systolic and diastolic function |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/495faf1d987c41ec8b93ea96ff9681f2 |
work_keys_str_mv |
AT eliasmeir depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT sarahleberer depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT annelieblumrich depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT georgvogler depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT anastasiavasiliades depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT sandradresen depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT carstenjaeger depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT yoanngloaguen depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT christianklose depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT dieterbeule depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT pchristianschulze depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT rolfbodmer depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT annaforystludwig depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction AT ulrichkintscher depletionofcardiaccardiolipinsynthasealterssystolicanddiastolicfunction |
_version_ |
1718419538521882624 |